Overview
10q22.3q23.3 microduplication syndrome (Orphanet: 276422) is a rare chromosomal anomaly caused by a duplication of genetic material on the long arm of chromosome 10, specifically in the 10q22.3 to 10q23.3 region. This region encompasses several genes, including BMPR1A and PTEN, which play important roles in cell growth and development. The syndrome is characterized by variable clinical features that can affect multiple body systems. Key clinical features reported in affected individuals include intellectual disability of variable severity, developmental delay (particularly speech and motor delays), behavioral abnormalities, and dysmorphic facial features. Facial features may include a broad forehead, hypertelorism, a flat nasal bridge, and low-set ears. Some patients may also present with growth abnormalities, hypotonia (reduced muscle tone), and skeletal anomalies. Congenital malformations affecting the heart and other organ systems have been described in some cases, though the phenotype is highly variable even among individuals carrying similar duplications. There is no specific cure or targeted therapy for 10q22.3q23.3 microduplication syndrome. Management is supportive and symptom-based, involving early intervention programs, speech therapy, occupational therapy, physical therapy, and special educational support. Regular developmental assessments and monitoring for associated complications are recommended. Genetic counseling is important for affected families to understand recurrence risks and the variable expressivity of this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 10q22.3q23.3 microduplication syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 10q22.3q23.3 microduplication syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 10q22.3q23.3 microduplication syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 10q22.3q23.3 microduplication syndrome.
Community
No community posts yet. Be the first to share your experience with 10q22.3q23.3 microduplication syndrome.
Start the conversation →Latest news about 10q22.3q23.3 microduplication syndrome
No recent news articles for 10q22.3q23.3 microduplication syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 10q22.3q23.3 microduplication syndrome
What is 10q22.3q23.3 microduplication syndrome?
10q22.3q23.3 microduplication syndrome (Orphanet: 276422) is a rare chromosomal anomaly caused by a duplication of genetic material on the long arm of chromosome 10, specifically in the 10q22.3 to 10q23.3 region. This region encompasses several genes, including BMPR1A and PTEN, which play important roles in cell growth and development. The syndrome is characterized by variable clinical features that can affect multiple body systems. Key clinical features reported in affected individuals include intellectual disability of variable severity, developmental delay (particularly speech and motor de
How is 10q22.3q23.3 microduplication syndrome inherited?
10q22.3q23.3 microduplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 10q22.3q23.3 microduplication syndrome typically begin?
Typical onset of 10q22.3q23.3 microduplication syndrome is neonatal. Age of onset can vary across affected individuals.